Published in J Virol on December 01, 1988
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virus. Nat Med (2005) 5.09
Intestinal microbiota promote enteric virus replication and systemic pathogenesis. Science (2011) 3.62
A plasmid-based reverse genetics system for animal double-stranded RNA viruses. Cell Host Microbe (2007) 2.48
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol (1991) 2.37
Differences in the capacity of reovirus strains to induce apoptosis are determined by the viral attachment protein sigma 1. J Virol (1995) 2.14
Junctional adhesion molecule-A is required for hematogenous dissemination of reovirus. Cell Host Microbe (2009) 1.91
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
Reovirus induces and benefits from an integrated cellular stress response. J Virol (2006) 1.74
Antibody is critical for the clearance of murine norovirus infection. J Virol (2008) 1.69
Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB. J Virol (2000) 1.68
Infectious subvirion particles of reovirus type 3 Dearing exhibit a loss in infectivity and contain a cleaved sigma 1 protein. J Virol (1995) 1.68
Mutations in reovirus outer-capsid protein sigma3 selected during persistent infections of L cells confer resistance to protease inhibitor E64. J Virol (1997) 1.66
A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro. J Virol (1997) 1.65
Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates. Nature (2014) 1.63
Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A (1991) 1.60
A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J Virol (1990) 1.57
The Nogo receptor NgR1 mediates infection by mammalian reovirus. Cell Host Microbe (2014) 1.56
Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J Virol (1993) 1.55
The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol (1989) 1.52
Mutations in type 3 reovirus that determine binding to sialic acid are contained in the fibrous tail domain of viral attachment protein sigma1. J Virol (1997) 1.50
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J Virol (1993) 1.48
Utilization of sialic acid as a coreceptor is required for reovirus-induced biliary disease. J Clin Invest (2003) 1.48
Mammalian reovirus, a nonfusogenic nonenveloped virus, forms size-selective pores in a model membrane. Proc Natl Acad Sci U S A (2006) 1.44
Beta1 integrin mediates internalization of mammalian reovirus. J Virol (2006) 1.43
Junctional adhesion molecule a serves as a receptor for prototype and field-isolate strains of mammalian reovirus. J Virol (2005) 1.43
Reovirus binding to cell surface sialic acid potentiates virus-induced apoptosis. J Virol (2001) 1.43
Antibody inhibits defined stages in the pathogenesis of reovirus serotype 3 infection of the central nervous system. J Exp Med (1989) 1.41
Detection of individual fluorescently labeled reovirions in living cells. Proc Natl Acad Sci U S A (1990) 1.41
Virion disassembly is required for apoptosis induced by reovirus. J Virol (2002) 1.40
Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J Clin Invest (2005) 1.34
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells. Mol Cancer (2009) 1.32
Peptides released from reovirus outer capsid form membrane pores that recruit virus particles. EMBO J (2008) 1.30
T cell-independent antibody-mediated clearance of polyoma virus in T cell-deficient mice. J Exp Med (1996) 1.29
The cellular protein P58IPK regulates influenza virus mRNA translation and replication through a PKR-mediated mechanism. J Virol (2006) 1.28
An improved reverse genetics system for mammalian orthoreoviruses. Virology (2009) 1.28
Reovirus variants selected during persistent infections of L cells contain mutations in the viral S1 and S4 genes and are altered in viral disassembly. J Virol (1997) 1.27
Structure of reovirus sigma1 in complex with its receptor junctional adhesion molecule-A. PLoS Pathog (2008) 1.25
Mutant cells selected during persistent reovirus infection do not express mature cathepsin L and do not support reovirus disassembly. J Virol (1999) 1.24
Reovirus apoptosis and virulence are regulated by host cell membrane penetration efficiency. J Virol (2007) 1.24
Cleavage susceptibility of reovirus attachment protein sigma1 during proteolytic disassembly of virions is determined by a sequence polymorphism in the sigma1 neck. J Virol (1998) 1.22
Role of immune cells in protection against and control of reovirus infection in neonatal mice. J Virol (1991) 1.20
Independent regulation of reovirus membrane penetration and apoptosis by the mu1 phi domain. PLoS Pathog (2008) 1.19
NPXY motifs in the beta1 integrin cytoplasmic tail are required for functional reovirus entry. J Virol (2008) 1.18
Reovirus growth in cell culture does not require the full complement of viral proteins: identification of a sigma1s-null mutant. J Virol (1998) 1.17
Sites and determinants of early cleavages in the proteolytic processing pathway of reovirus surface protein sigma3. J Virol (2002) 1.17
Protective antibodies inhibit reovirus internalization and uncoating by intracellular proteases. J Virol (1994) 1.17
Role of immunoglobulin A in protection against reovirus entry into Murine Peyer's patches. J Virol (2001) 1.17
Crystal structure of reovirus attachment protein σ1 in complex with sialylated oligosaccharides. PLoS Pathog (2011) 1.17
Complete in vitro assembly of the reovirus outer capsid produces highly infectious particles suitable for genetic studies of the receptor-binding protein. J Virol (2001) 1.17
Efficiency of viral entry determines the capacity of murine erythroleukemia cells to support persistent infections by mammalian reoviruses. J Virol (1997) 1.16
Interferon-inducible transmembrane protein 3 (IFITM3) restricts reovirus cell entry. J Biol Chem (2013) 1.15
Genetic mapping of reovirus virulence and organ tropism in severe combined immunodeficient mice: organ-specific virulence genes. J Virol (1995) 1.13
Thermostabilizing mutations in reovirus outer-capsid protein mu1 selected by heat inactivation of infectious subvirion particles. Virology (2007) 1.13
Type I interferons produced by hematopoietic cells protect mice against lethal infection by mammalian reovirus. J Exp Med (2007) 1.13
Addition of exogenous protease facilitates reovirus infection in many restrictive cells. J Virol (2002) 1.13
Gene-specific inhibition of reovirus replication by RNA interference. J Virol (2006) 1.12
Requirements for the formation of membrane pores by the reovirus myristoylated micro1N peptide. J Virol (2009) 1.12
Identification of the viral genes responsible for growth of strains of reovirus in cultured mouse heart cells. J Clin Invest (1991) 1.10
Identification of functional domains in reovirus replication proteins muNS and mu2. J Virol (2009) 1.10
Neutralizing antibodies in Borna disease virus-infected rats. J Virol (1995) 1.10
Reovirus mu2 protein inhibits interferon signaling through a novel mechanism involving nuclear accumulation of interferon regulatory factor 9. J Virol (2008) 1.09
The reovirus M1 gene determines the relative capacity of growth of reovirus in cultured bovine aortic endothelial cells. J Clin Invest (1993) 1.09
Regional differences in viral growth and central nervous system injury correlate with apoptosis. J Virol (2004) 1.08
Penetration of the nervous systems of suckling mice by mammalian reoviruses. J Virol (1991) 1.06
Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice. J Virol (2003) 1.05
Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer's patches. J Virol (2004) 1.05
Reovirus forms neo-organelles for progeny particle assembly within reorganized cell membranes. MBio (2014) 1.04
Reovirus nonstructural protein sigma1s is required for establishment of viremia and systemic dissemination. Proc Natl Acad Sci U S A (2009) 1.04
Analysis of antibody responses to predominant linear epitopes of Theiler's murine encephalomyelitis virus. J Virol (1994) 1.04
Transport to late endosomes is required for efficient reovirus infection. J Virol (2012) 1.03
IkappaB kinase subunits alpha and gamma are required for activation of NF-kappaB and induction of apoptosis by mammalian reovirus. J Virol (2006) 1.02
Activation of protein kinase R is required for induction of stress granules by respiratory syncytial virus but dispensable for viral replication. Virology (2011) 1.02
Reovirus preferentially infects the basolateral surface and is released from the apical surface of polarized human respiratory epithelial cells. J Infect Dis (2008) 1.02
Circulating immunoglobulin G can play a critical role in clearance of intestinal reovirus infection. J Virol (1996) 1.00
The reovirus sigma1s protein is a determinant of hematogenous but not neural virus dissemination in mice. J Virol (2011) 0.99
Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice. J Virol (1990) 0.99
Persistent reovirus infections of L cells select mutations in viral attachment protein sigma1 that alter oligomer stability. J Virol (1996) 0.99
The GM2 glycan serves as a functional coreceptor for serotype 1 reovirus. PLoS Pathog (2012) 0.99
Identification of an NF-kappaB-dependent gene network in cells infected by mammalian reovirus. J Virol (2006) 0.99
Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice. Antimicrob Agents Chemother (1994) 0.98
Bid regulates the pathogenesis of neurotropic reovirus. PLoS Pathog (2010) 0.98
A pathway for entry of reoviruses into the host through M cells of the respiratory tract. J Exp Med (1994) 0.98
Detection of mammalian reovirus RNA by using reverse transcription-PCR: sequence diversity within the lambda3-encoding L1 gene. J Clin Microbiol (2002) 0.96
Reovirus activates a caspase-independent cell death pathway. MBio (2013) 0.95
Postinfection treatment with antiviral serum results in survival of neural cells productively infected with virulent poliovirus. J Virol (1992) 0.95
Nonstructural protein sigma1s is a determinant of reovirus virulence and influences the kinetics and severity of apoptosis induction in the heart and central nervous system. J Virol (2005) 0.95
Adaptation of reovirus to growth in the presence of protease inhibitor E64 segregates with a mutation in the carboxy terminus of viral outer-capsid protein sigma3. J Virol (2001) 0.94
Reovirus uses multiple endocytic pathways for cell entry. J Virol (2012) 0.94
Genetic and pharmacologic alteration of cathepsin expression influences reovirus pathogenesis. J Virol (2009) 0.93
Apoptosis induced by mammalian reovirus is beta interferon (IFN) independent and enhanced by IFN regulatory factor 3- and NF-κB-dependent expression of Noxa. J Virol (2011) 0.93
Involvement of the interferon-regulated antiviral proteins PKR and RNase L in reovirus-induced shutoff of cellular translation. J Virol (2005) 0.93
Formation of the factory matrix is an important, though not a sufficient function of nonstructural protein mu NS during reovirus infection. Virology (2008) 0.92
A post-entry step in the mammalian orthoreovirus replication cycle is a determinant of cell tropism. J Biol Chem (2010) 0.92
Utilization of sialylated glycans as coreceptors enhances the neurovirulence of serotype 3 reovirus. J Virol (2012) 0.91
Thermolabilizing pseudoreversions in reovirus outer-capsid protein micro 1 rescue the entry defect conferred by a thermostabilizing mutation. J Virol (2007) 0.91
Parallel mechanisms in neuropathogenesis of enteric virus infections. J Virol (1991) 0.91
Reovirus infection in rat lungs as a model to study the pathogenesis of viral pneumonia. J Virol (1996) 0.89
Reovirus variants selected for resistance to ammonium chloride have mutations in viral outer-capsid protein sigma3. J Virol (2006) 0.89
THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J (1963) 61.56
Polypeptide components of virions, top component and cores of reovirus type 3. Virology (1969) 9.83
Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J Immunol (1970) 6.58
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). J Immunol (1973) 4.78
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol (1988) 4.77
Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A (1977) 3.97
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis (1980) 3.27
Isolation of the anticomplementary protein from cobra venom and its mode of action on C3. J Immunol (1971) 3.25
Protection against lethal challenge of BALB/c mice by passive transfer of monoclonal antibodies to five glycoproteins of herpes simplex virus type 2. Infect Immun (1982) 3.02
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature (1982) 2.64
Protection against 17D yellow fever encephalitis in mice by passive transfer of monoclonal antibodies to the nonstructural glycoprotein gp48 and by active immunization with gp48. J Immunol (1985) 2.63
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Murine hepatitis virus-4 (strain JHM)-induced neurologic disease is modulated in vivo by monoclonal antibody. Virology (1984) 2.57
Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology (1982) 2.55
Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med (1977) 2.53
Use of monoclonal antibody directed against herpes simplex virus glycoproteins to protect mice against acute virus-induced neurological disease. Infect Immun (1981) 2.49
MURINE INFECTION WITH REOVIRUS: I. PATHOLOGY OF THE ACUTE PHASE. Br J Exp Pathol (1963) 2.33
Role of the immune response in recovery from Sindbis virus encephalitis in mice. J Immunol (1977) 2.32
Mechanisms of neutralization of animal viruses. J Gen Virol (1984) 2.16
The interaction of a series of hybridoma IgGs with reovirus particles. Demonstration that the core protein lambda 2 is exposed on the particle surface. Virology (1981) 1.98
A new mechanism for the neutralization of enveloped viruses by antiviral antibody. Nature (1986) 1.94
Molecular basis of viral neurotropism: experimental reovirus infection. Neurology (1985) 1.94
Use of monoclonal antibodies for analysis of antibody-dependent immunity to ocular herpes simplex virus type 1 infection. Infect Immun (1982) 1.92
Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein. Virology (1983) 1.86
Antiviral antibody reacting on the plasma membrane alters measles virus expression inside the cell. Nature (1979) 1.75
Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence. Proc Natl Acad Sci U S A (1982) 1.71
Pathogenesis of herpes simplex virus in congenitally athymic mice: the relative roles of cell-mediated and humoral immunity. J Gen Virol (1982) 1.70
Lethal 17D yellow fever encephalitis in mice. I. Passive protection by monoclonal antibodies to the envelope proteins of 17D yellow fever and dengue 2 viruses. J Gen Virol (1986) 1.67
Antibody-mediated recovery from subcutaneous herpes simplex virus type 2 infection. Infect Immun (1978) 1.59
Elucidation of the topography and determination of the protective epitopes on the E glycoprotein of Saint Louis encephalitis virus by passive transfer with monoclonal antibodies. J Immunol (1984) 1.58
Host defenses in herpes simplex infections of the nervous system: effect of antibody on disease and viral spread. Infect Immun (1979) 1.58
Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. J Gen Virol (1986) 1.55
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis (1974) 1.51
Protective effect of monoclonal antibodies on lethal mouse hepatitis virus infection in mice. J Virol (1986) 1.47
Alterations in expression of measles virus polypeptides by antibody: molecular events in antibody-induced antigenic modulation. J Immunol (1980) 1.45
Neutralizing antibodies to visna lentivirus: mechanism of action and possible role in virus persistence. J Virol (1986) 1.45
Passive immune protection by herpes simplex virus-specific monoclonal antibodies and monoclonal antibody-resistant mutants altered in pathogenicity. J Virol (1985) 1.45
Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice. J Virol (1986) 1.43
Ocular infection with herpes simplex virus type 1: prevention of acute herpetic encephalitis by systemic administration of virus-specific antibody. J Infect Dis (1979) 1.39
The effect of complement depletion on the course of Sindbis virus infection in mice. J Immunol (1978) 1.38
Pathogenesis of viral infections. Basic concepts derived from the reovirus model. N Engl J Med (1985) 1.38
Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature (1981) 1.30
Alternative pathway for the activation of complement in human serum. Formation and composition of the complex with cobra venom factor that cleaves the third component of complement. Hoppe Seylers Z Physiol Chem (1974) 1.29
Protective effects of glycoprotein-specific monoclonal antibodies on the course of experimental mumps virus meningoencephalitis. J Virol (1985) 1.23
Role of Fc fragments in antibody-mediated recovery from ocular and subcutaneous herpes simplex virus infections. Infect Immun (1981) 1.21
Inhibitory effects of passive antibody on virulent poliovirus excretion and on immune response in chimpanzees. Bull Johns Hopkins Hosp (1960) 1.20
The role of antibody in recovery from experimental rabies. I. Effect of depletion of B and T cells. J Immunol (1978) 1.19
Role of complement and the Fc portion of immunoglobulin G in immunity to Venezuelan equine encephalomyelitis virus infection with glycoprotein-specific monoclonal antibodies. J Virol (1985) 1.18
IgG-mediated viral clearance in experimental infection with herpes simplex virus type 1: role for neutralization and Fc-dependent functions but not C' cytolysis and C5 chemotaxis. J Infect Dis (1985) 1.14
The cobra venom factor-dependent C3 convertase of human complement. A kinetic and thermodynamic analysis of a protease acting on its natural high molecular weight substrate. J Biol Chem (1982) 1.14
Immune complex effects on murine macrophages. I. Immune complexes suppress interferon-gamma induction of Ia expression. J Immunol (1985) 1.13
Reovirus type 3 encephalitis: observations of virus-cell interactions in neural tissues. II. Electron microscopic studies. Lab Invest (1971) 1.13
Mechanisms of monoclonal antibody-mediated protection against virulent Semliki Forest virus. J Virol (1985) 1.11
Breakdown of the blood--cerebrospinal fluid barrier to immunoglobulin in mice injected intracerebrally with a neurotropic influenza A virus. Post-exposure treatment with monoclonal antibody promotes recovery. J Neuroimmunol (1981) 1.07
Experimental studies on passive immunization against poliomyelitis. II. The prophylactic effect of human gamma globulin on paralytic poliomyelitis in cynomolgus monkeys after virus feeding. Am J Hyg (1952) 1.07
A study of the effect of antiserum on poliovirus infection induced by the intraspinal inoculation of rhesus monkeys. J Immunol (1958) 1.05
Suppression of the immune response to Listeria monocytogenes. I. Immune complexes inhibit resistance. J Immunol (1984) 1.03
Intraneuronal IgG in the central nervous system: uptake by retrograde axonal transport. Neurology (1987) 1.02
Uptake of reovirus serotype 1 by the lungs from the bloodstream is mediated by the viral hemagglutinin. J Virol (1988) 1.01
Study of protein characteristics that influence entry into the cerebrospinal fluid of normal mice and mice with encephalitis. J Clin Invest (1982) 0.96
Monoclonal antibodies against the fusion protein are protective in necrotizing mumps meningoencephalitis. J Virol (1986) 0.96
Experimental poliomyelitis following intramuscular virus injection. II. Viremia and the effect of antibody. Bull Johns Hopkins Hosp (1961) 0.90
Immunotherapy of murine leukemia. IX. The requirement for the Fc portion of antibody for successful passive serum therapy of Friend leukemia virus-induced disease. Virology (1983) 0.90
Experimental poliomyelitis following intramuscular virus injection. III. The effect of passive antibody on paralysis and viremia. Bull Johns Hopkins Hosp (1962) 0.89
Topographical analysis of epitope relationships on the envelope glycoprotein of yellow fever 17D vaccine and the wild type Asibi parent virus. Virology (1986) 0.88
Expression of reovirus type 3 (Dearing) sigma 1 and sigma s polypeptides in Escherichia coli. J Gen Virol (1987) 0.86
Retrograde transport and differential accumulation of serum proteins in motor neurons: implications for motor neuron diseases. Neurology (1987) 0.85
Suppression of immune response to Listeria monocytogenes: mechanism(s) of immune complex suppression. Infect Immun (1985) 0.85
A study on serotherapy of poliomyelitis in rhesus monkeys. Br J Exp Pathol (1959) 0.85
Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J Virol (1989) 5.77
A calcineurin-dependent transcriptional pathway controls skeletal muscle fiber type. Genes Dev (1998) 5.14
Sigma 1 protein of mammalian reoviruses extends from the surfaces of viral particles. J Virol (1988) 4.77
Molecular basis of reovirus virulence: role of the S1 gene. Proc Natl Acad Sci U S A (1977) 3.97
Genome RNAs and polypeptides of reovirus serotypes 1, 2, and 3. J Virol (1977) 3.87
Isolation and preliminary genetic and biochemical characterization of temperature-sensitive mutants of reovirus. Virology (1969) 3.66
Intracellular digestion of reovirus particles requires a low pH and is an essential step in the viral infectious cycle. J Virol (1987) 3.65
MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO J (2000) 3.59
Absolute linkage of virulence and central nervous system cell tropism of reoviruses to viral hemagglutinin. J Infect Dis (1980) 3.27
A protein encoded within the Down syndrome critical region is enriched in striated muscles and inhibits calcineurin signaling. J Biol Chem (2000) 3.26
Thymidine kinase-negative herpes simplex virus mutants establish latency in mouse trigeminal ganglia but do not reactivate. Proc Natl Acad Sci U S A (1989) 3.26
Intestinal M cells: a pathway for entry of reovirus into the host. Science (1981) 3.23
Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circ Res (2000) 3.04
Creutzfeldt-Jakob disease and bovine spongiform encephalopathy: any connection? BMJ (1995) 2.74
Myocyte-enriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A (2001) 2.64
Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science (1986) 2.61
Evidence for functional domains on the reovirus type 3 hemagglutinin. Virology (1982) 2.55
Neutralization of reovirus: the gene responsible for the neutralization antigen. J Exp Med (1977) 2.53
Genetics of reovirus: identification of the ds RNA segments encoding the polypeptides of the mu and sigma size classes. Virology (1978) 2.51
HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology (1999) 2.49
Host restriction of Friend leukemia virus. Role of the viral outer coat. Proc Natl Acad Sci U S A (1973) 2.44
Proteolytic digestion of reovirus in the intestinal lumens of neonatal mice. J Virol (1989) 2.38
Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO J (2001) 2.38
Monoclonal antibodies to reovirus reveal structure/function relationships between capsid proteins and genetics of susceptibility to antibody action. J Virol (1991) 2.37
Activation and characterization of the reovirus transcriptase: genetic analysis. J Virol (1982) 2.36
Molecular basis of reovirus virulence. Role of the M2 gene. J Exp Med (1980) 2.32
A carboxy-terminal fragment of protein mu 1/mu 1C is present in infectious subvirion particles of mammalian reoviruses and is proposed to have a role in penetration. J Virol (1992) 2.29
Identification of the gene coding for the hemagglutinin of reovirus. Virology (1978) 2.28
Atypical herpes simplex virus encephalitis diagnosed by PCR amplification of viral DNA from CSF. Neurology (1998) 2.26
Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection. Cell (1981) 2.23
Intracellular synthesis of measles virus-specified polypeptides. J Virol (1978) 2.21
Polymorphism of the migration of double-stranded RNA genome segments of reovirus isolates from humans, cattle, and mice. J Virol (1979) 2.15
Identification of attenuating mutations on the reovirus type 3 S1 double-stranded RNA segment with a rapid sequencing technique. J Virol (1986) 2.15
Characterization of a zinc blotting technique: evidence that a retroviral gag protein binds zinc. Proc Natl Acad Sci U S A (1988) 2.13
Attenuated reovirus type 3 strains generated by selection of haemagglutinin antigenic variants. Nature (1982) 2.11
Mammalian reoviruses contain a myristoylated structural protein. J Virol (1991) 2.09
Reovirus inhibition of cellular RNA and protein synthesis: role of the S4 gene. Virology (1982) 2.08
Interaction of reovirus with cell surface receptors. I. Murine and human lymphocytes have a receptor for the hemagglutinin of reovirus type 3. J Immunol (1980) 2.06
Reovirus M2 gene is associated with chromium release from mouse L cells. J Virol (1993) 1.99
Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3. Mol Cell Biol (1988) 1.96
Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology (1983) 1.95
Sequence of reovirus haemagglutinin predicts a coiled-coil structure. Nature (1985) 1.95
Molecular basis of viral neurotropism: experimental reovirus infection. Neurology (1985) 1.94
Reovirus infection and tissue injury in the mouse central nervous system are associated with apoptosis. J Virol (1997) 1.90
The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal. Am J Med (1967) 1.88
A genetic map of reovirus. II. Assignment of the double-stranded RNA-negative mutant groups C, D, and E to genome segments. Virology (1978) 1.87
Genetic studies on the mechanism of chemical and physical inactivation of reovirus. J Gen Virol (1982) 1.84
Reovirus-induced apoptosis of MDCK cells is not linked to viral yield and is blocked by Bcl-2. J Virol (1997) 1.84
Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism. Science (1983) 1.82
Binding and transepithelial transport of immunoglobulins by intestinal M cells: demonstration using monoclonal IgA antibodies against enteric viral proteins. J Cell Biol (1989) 1.82
Mice without myoglobin. Nature (1998) 1.78
Progressive esophagitis from acyclovir-resistant herpes simplex. Clinical roles for DNA polymerase mutants and viral heterogeneity? Ann Intern Med (1989) 1.78
Herpes simplex virus infection as a cause of benign recurrent lymphocytic meningitis. Ann Intern Med (1994) 1.77
Temperature-sensitive mutants of reovirus type 3: studies on the synthesis of viral RNA. Virology (1972) 1.77
Genetic and molecular mechanisms of viral pathogenesis: implications for prevention and treatment. Nature (1982) 1.75
Hemagglutinin of rabies and some other bullet-shaped viruses. Proc Soc Exp Biol Med (1968) 1.74
Cardiac-specific LIM protein FHL2 modifies the hypertrophic response to beta-adrenergic stimulation. Circulation (2001) 1.74
Mechanisms of viral pathogenesis. Distinct forms of reoviruses and their roles during replication in cells and host. J Clin Invest (1991) 1.73
A genetic map of reovirus. 1. Correlation of genome RNAs between serotypes 1, 2, and 3. Virology (1978) 1.72
Structure of the reovirus cell-attachment protein: a model for the domain organization of sigma 1. J Virol (1990) 1.71
Molecular basis of reovirus neurovirulence: role of the M2 gene in avirulence. Proc Natl Acad Sci U S A (1982) 1.71
Isolation and biochemical characterization of the mammalian reovirus type 3 cell-surface receptor. Proc Natl Acad Sci U S A (1985) 1.70
Molecular structure of the cell-attachment protein of reovirus: correlation of computer-processed electron micrographs with sequence-based predictions. J Virol (1990) 1.69
Reovirus-induced apoptosis requires activation of transcription factor NF-kappaB. J Virol (2000) 1.68
Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF. Proc Natl Acad Sci U S A (2000) 1.68
Ion channels induced in lipid bilayers by subvirion particles of the nonenveloped mammalian reoviruses. Proc Natl Acad Sci U S A (1993) 1.64
Growth and survival of reovirus in intestinal tissue: role of the L2 and S1 genes. J Virol (1989) 1.64
Identification of a hemagglutinin-specific idiotype associated with reovirus recognition shared by lymphoid and neural cells. J Exp Med (1982) 1.64
The sigma 1 protein determines the extent of spread of reovirus from the gastrointestinal tract of mice. Virology (1983) 1.63
Reovirus-induced apoptosis is mediated by TRAIL. J Virol (2000) 1.62
Direct spread of reovirus from the intestinal lumen to the central nervous system through vagal autonomic nerve fibers. Proc Natl Acad Sci U S A (1991) 1.60
Role of the mu 1 protein in reovirus stability and capacity to cause chromium release from host cells. J Virol (1996) 1.58
Identification of a new polypeptide coded by reovirus gene S1. J Virol (1985) 1.57
A sigma 1 region important for hemagglutination by serotype 3 reovirus strains. J Virol (1990) 1.57
Why the smallpox virus stocks should not be destroyed. Science (1993) 1.56
Intraluminal proteolytic activation plays an important role in replication of type 1 reovirus in the intestines of neonatal mice. J Virol (1990) 1.56
Protective anti-reovirus monoclonal antibodies and their effects on viral pathogenesis. J Virol (1993) 1.55
The interaction of mammalian reoviruses with the cytoskeleton of monkey kidney CV-1 cells. Virology (1982) 1.55
Temperature-sensitive mutants of reovirus type 3 features of genetic recombination. Virology (1971) 1.53
Genetic manipulation of reovirus--a model for modification of disease. N Engl J Med (1972) 1.53
The reovirus M1 gene, encoding a viral core protein, is associated with the myocarditic phenotype of a reovirus variant. J Virol (1989) 1.52
Immune response in subacute sclerosing panencephalitis: reduced antibody response to the matrix protein of measles virus. J Immunol (1979) 1.52
Crystallization of the reovirus type 3 Dearing core. Crystal packing is determined by the lambda 2 protein. J Mol Biol (1990) 1.51
Ammonium chloride prevents lytic growth of reovirus and helps to establish persistent infection in mouse L cells. Science (1983) 1.50
Temperature-sensitive mutants of reovirus type 3: defects in viral maturation as studied by immunofluorescence and electron microscopy. Virology (1971) 1.50
Generation of cytolytic T lymphocytes after reovirus infection: role of S1 gene. Proc Natl Acad Sci U S A (1979) 1.50
Derivation and characterization of an efficiently myocarditic reovirus variant. J Virol (1989) 1.49
Cells and viruses with mutations affecting viral entry are selected during persistent infections of L cells with mammalian reoviruses. J Virol (1993) 1.48
Syngeneic monoclonal antiidiotype can induce cellular immunity to reovirus. J Exp Med (1984) 1.48
Cell receptors for the mammalian reovirus. I. Syngeneic monoclonal anti-idiotypic antibody identifies a cell surface receptor for reovirus. J Immunol (1983) 1.46
Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol (1990) 1.44